Venter Institute, Yumanity among the biopharmaceutical beneficiaries of PPP loans
Yesumanity, the J. Craig Venter Institute and dozens of other companies in the biotechnology industry have received Paycheque Protection Program ready, according to data released Monday.
The J. Craig Venter Institute has secured a loan of more than $ 2 million covering more than 150 employees. Neurodegeneration-focused startup Yumanity Therapeutics has received more than $ 1 million under the program. LabCentral, an incubator in Cambridge, Massachusetts, received approximately $ 720,000 from the program. And the American Cancer Research Association, which held its annual convention practically this year, received enough of the program to pay more than 200 people.
What is that?
STAT + is STAT’s premium subscription service for in-depth coverage and analysis in biotechnology, pharmacy, policy and life sciences. Our award-winning team covers the news on Wall Street, political developments in Washington, early scientific breakthroughs and clinical trial results, and the disruption of healthcare in Silicon Valley and beyond.
What is included?
- Daily reports and analyzes
- The most comprehensive coverage in the industry by a team of powerful journalists
- Subscriber newsletters
- Daily newsletters to keep you informed about the most important news in the sector
- STAT + conversations
- Weekly opportunities to engage with our journalists and leading industry experts in live video chats
- Exclusive industry events
- Premium access to subscriber-only networking events nationwide
- The best reporters in the industry
- The most trusted and connected newsroom in the healthcare industry
- And much more
- Exclusive interviews with industry leaders, profiles and high-end tools, like our CRISPR Trackr.